CD4 and CD8 monoclonal antibody therapy in canine renal allografts.
Therapy with CD4 and CD8 monoclonal antibodies was evaluated in dogs which received double-haplotype MHC-mismatched renal allografts. Neither CD4 nor CD8 monoclonal antibodies given alone prolonged allografts survival (creatinine > or = 300 micromol/l) beyond 7 days. However, combined therapy...
Egile Nagusiak: | Watson, C, Cobbold, S, Davies, H, Rebello, P, Waldmann, H, Calne, R, Metcalfe, S |
---|---|
Formatua: | Journal article |
Hizkuntza: | English |
Argitaratua: |
1994
|
Antzeko izenburuak
-
Immunosuppression of canine renal allograft recipients by CD4 and CD8 monoclonal antibodies.
nork: Watson, C, et al.
Argitaratua: (1994) -
CD4 and CD8 monoclonal antibody therapy: strategies to prolong renal allograft survival in the dog.
nork: Watson, C, et al.
Argitaratua: (1993) -
CD4 and CD8 monoclonal antibody therapy in the dog: strategies to induce tolerance to renal allografts.
nork: Watson, C, et al.
Argitaratua: (1995) -
CD4 monoclonal antibodies in the preclinical dog renal allograft model.
nork: Watson, C, et al.
Argitaratua: (1993) -
Production, selection, and testing of monoclonal antibodies to canine leukocytes in the dog kidney allograft model.
nork: Davies, H, et al.
Argitaratua: (1994)